MXCT
MaxCyte Inc
1.20$
-0.4%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +29.7% | +32.1% | +14.0% | +19.2% | +29.7% | +21.0% | +29.5% | +30.6% | -6.7% | -6.4% | -14.5% | |
| – | +7.8% | +26.7% | +11.1% | +26.6% | +35.8% | +10.7% | +31.8% | +39.8% | -7.0% | +49.7% | -12.4% | |
| – | +33.1% | +32.7% | +14.3% | +18.3% | +29.0% | +22.4% | +29.2% | +29.5% | -6.7% | -13.7% | -15.0% | |
| – | +20.8% | +56.1% | +140.3% | -0.4% | +56.5% | +0.8% | -13.1% | +26.7% | +22.1% | -6.7% | -6.3% | |
| – | +8.1% | +57.7% | +7.5% | +16.9% | +5.1% | +32.7% | +153.4% | +38.3% | +16.4% | -1.2% | -5.3% | |
| – | +20.5% | +51.7% | +59.5% | +6.5% | +35.7% | +9.2% | +40.6% | +37.3% | +27.5% | -2.5% | -12.9% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +25.5% | -9.5% | -2.0% | -1.7% | +10.8% | +21.2% | +26.5% | -87.8% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -9.8% | – | – | +299.9% | +21.2% | +26.5% | -462.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.